Drug spending increased by 13.6% in 2023 to $722.5 billion, according to recent research. It found divergent trends for clinic [...] …
Category: General
As 340B stakeholders continue to hold out for long-awaited congressional action that could overhaul the discount drug pricing program, some [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Kansas Gov. Laura Kelly (D) signed a sweeping state budget bill late Wednesday that contains a provision to prohibit drugmaker [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A small business lobbying organization, created as a more conservative alternative to the U.S. Chamber of Commerce, this week launched [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After Virginia Gov. Glenn Youngkin (R) amended a bill to delay legislation prohibiting certain drugmaker 340B contract pharmacy restrictions in [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer AbbVie is adding a cancer treatment to the list of drug products that only will be available to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Q: Tell us some interesting details about your company’s history.
Sectyr was founded to achieve the goal of helping our customers with Continuous Program Compliance. While we have many customers
…
Q: Tell us some interesting details about your company’s history.
At CPS Solutions, LLC. (CPS), we’ve been partnering with healthcare organizations to transform pharmacy results for over 50 years.
In
…
SPONSORED CONTENT
On February 2, six senators known as the “Gang of Six” – John Thune, Debbie Stabenow, Shelley Moore Capito, Tammy Baldwin, Jerry Moran and Ben Cardin – unveiled a discussion draft bill intended to preserve the 340B program and codify in statute
…
SPONSORED CONTENT
In 2024, pharmacy will play an even more significant and critical role in health systems’ financial and operational performance nationwide. While health systems face daunting challenges, increasing risks, and suffocating regulatory and compliance burdens, high-performing pharmacy organizations
…